FDA Panel Backs Inhaled, Injection-Free Diabetes Drug
By Susan Heavey The advisers said there was not enough data on the potential cancer risk and called for more long-term study
fda panel back inhaled injection free diabetes drug susan heavey adviser say datum potential cancer risk call long term study